Current Management and Progress in Radiotherapy for Small Cell Lung Cancer

Current Management and Progress in Radiotherapy for Small Cell Lung Cancer

Radiotherapy (RT) and chemotherapy continue to be widely utilized in small cell lung cancer (SCLC) management. In most limited stage (LS)-SCLC cases, the standard initial therapy remains concurrent chemoradiotherapy (CRT), typically with an etoposide and platinum-based regimen. Hyperfractionated twi...

Full description

Bibliographic Details
Main Authors: Michael C. Tjong, David Y. Mak, Jeevin Shahi, George J. Li, Hanbo Chen, Alexander V. Louie
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Oncology
Subjects:
small cell lung cancer (SCLC)
Radiotherapy—Chemotherapy
review (article)
immunotherapy
stereotactic ablative body radiation
radiotherapy—adverse effects
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2020.01146/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2020.01146/full

Similar Items